Sobi Acquires Dova in US$915 M Deal

By Michelle Liu

Pharma Deals Review: Vol 2019 Issue 10 (Table of Contents)

Published: 9 Oct-2019

DOI: 10.3833/pdr.v2019.i10.2459     ISSN: 1756-7874

Section: Mergers & Acquisitions



Expanding its haematology portfolio, Swedish Orphan Biovitrum (Sobi) has agreed to acquire Dova Pharmaceuticals for up to US$915 M...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details